Martell Christopher 4
4 · Candel Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Martell Christopher
Director
Transactions
- Award
Common Stock
2025-06-25$4.67/sh+111,349$520,000→ 111,349 total(indirect: By Spouse)
Holdings
- 152,000(indirect: By LLC)
Common Stock
- 283,514(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
- [F2]Shares held by Spouse.
- [F3]Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
- [F4]Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.